Tissue plasminogen activator receptor

There is no well-established molecular entity known as "Tissue plasminogen activator receptor" in current biomedical literature. Tissue plasminogen activator (tPA) is a serine protease enzyme that catalyzes the conversion of plasminogen to plasmin, leading to fibrin clot breakdown[2][3][5][8]. tPA does interact with several cell surface proteins such as low-density lipoprotein receptor-related protein 1 (LRP1), mannose receptor (MR), annexin A2/S100A10, and cation-independent mannose 6-phosphate receptor (CI-MPR) for internalization and regulation; however, none of these are universally recognized as "the" tPA receptor, nor is there a dedicated membrane protein termed "Tissue plasminogen activator receptor"[1][4][6][5]. The commonly referenced cell surface partner in the plasminogen activation system is the urokinase plasminogen activator receptor (uPAR), but this is specific to the urokinase-type activator, not tPA[7][6]. Summary: The term "Tissue plasminogen activator receptor" is incorrect or ambiguous—no single, distinct receptor by this name is recognized as a canonical target. There are cell surface receptors and binding proteins that interact with tPA, but none that fit the strict definition or usage implied by the query.